The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-[5-({3-[5-(Acetyl-hydroxy-amino)-pentylcarbamoyl]-propionyl}-hydroxy-amino)-pentyl]-N'-{5-[(3-chloro-adamantane-1-carbonyl)-amino]-pentyl}-N'-hydroxy-succinamide ID: ALA4205430
Chembl Id: CHEMBL4205430
PubChem CID: 145976114
Max Phase: Preclinical
Molecular Formula: C36H61ClN6O9
Molecular Weight: 757.37
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)C12CC3CC(CC(Cl)(C3)C1)C2
Standard InChI: InChI=1S/C36H61ClN6O9/c1-27(44)41(50)18-8-2-5-15-38-30(45)11-13-32(47)42(51)19-9-3-6-16-39-31(46)12-14-33(48)43(52)20-10-4-7-17-40-34(49)35-22-28-21-29(23-35)25-36(37,24-28)26-35/h28-29,50-52H,2-26H2,1H3,(H,38,45)(H,39,46)(H,40,49)
Standard InChI Key: HTIJXULDWUPWCN-UHFFFAOYSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 757.37Molecular Weight (Monoisotopic): 756.4189AlogP: 3.66#Rotatable Bonds: 25Polar Surface Area: 208.92Molecular Species: NEUTRALHBA: 9HBD: 6#RO5 Violations: 2HBA (Lipinski): 15HBD (Lipinski): 6#RO5 Violations (Lipinski): 3CX Acidic pKa: 7.92CX Basic pKa: 0.48CX LogP: 0.44CX LogD: 0.32Aromatic Rings: ┄Heavy Atoms: 52QED Weighted: 0.03Np Likeness Score: -0.15
References 1. Telfer TJ, Liddell JR, Duncan C, White AR, Codd R.. (2017) Adamantyl- and other polycyclic cage-based conjugates of desferrioxamine B (DFOB) for treating iron-mediated toxicity in cell models of Parkinson's disease., 27 (8): [PMID:28285915 ] [10.1016/j.bmcl.2017.03.001 ]